These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26224289)

  • 21. Reduced myelinogenesis and recovery in hyperphenylalaninemic rats. Correlation between brain phenylalanine levels, characteristic brain enzymes for myelination, and brain development.
    Burri R; Steffen C; Stieger S; Brodbeck U; Colombo JP; Herschkowitz N
    Mol Chem Neuropathol; 1990; 13(1-2):57-69. PubMed ID: 2095783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term changes in glutamatergic synaptic transmission in phenylketonuria.
    Glushakov AV; Glushakova O; Varshney M; Bajpai LK; Sumners C; Laipis PJ; Embury JE; Baker SP; Otero DH; Dennis DM; Seubert CN; Martynyuk AE
    Brain; 2005 Feb; 128(Pt 2):300-7. PubMed ID: 15634735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental phenylketonuria: replacement of carboxyl terminal tyrosine by phenylalanine in infant rat brain tubulin.
    Rodriguez JA; Borisy GG
    Science; 1979 Oct; 206(4417):463-5. PubMed ID: 574315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free amino acid pool in the brain of mice homozygous for the gene "dilute lethal".
    Simler S; Essayag S; Ledig M; Koehl C; Mandel P
    J Neurosci Res; 1977; 3(4):281-7. PubMed ID: 566796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and biochemical correlates of diet change in phenylketonuria.
    Anderson VE; Siegel FS
    Pediatr Res; 1976 Jan; 10(1):10-7. PubMed ID: 1246460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery of neurogenic amines in phenylketonuria mice after liver-targeted gene therapy.
    Yagi H; Sanechika S; Ichinose H; Sumi-Ichinose C; Mizukami H; Urabe M; Ozawa K; Kume A
    Neuroreport; 2012 Jan; 23(1):30-4. PubMed ID: 22107842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered expression of myocilin in the brain of a mouse model for phenylketonuria (PKU).
    Surendran S; Matalon D; Tyring SK; Rady PL; Velagaleti GV; Matalon R
    Neurosci Lett; 2005 Jul; 382(3):323-6. PubMed ID: 15925112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathogenetic mechanisms in phenylketonuria: disorders affecting the metabolism of neurotransmitters and the antioxidant system].
    Ormazábal A; Artuch R; Vilaseca MA; García-Cazorla A; Campistol J
    Rev Neurol; 2004 Nov 16-30; 39(10):956-61. PubMed ID: 15573314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) mice.
    Embury JE; Charron CE; Martynyuk A; Zori AG; Liu B; Ali SF; Rowland NE; Laipis PJ
    Brain Res; 2007 Jan; 1127(1):136-50. PubMed ID: 17112485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control.
    de Sonneville LM; Huijbregts SC; van Spronsen FJ; Verkerk PH; Sergeant JA; Licht R
    Mol Genet Metab; 2010; 99 Suppl 1():S10-7. PubMed ID: 20123462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.
    Möller HE; Weglage J; Bick U; Wiedermann D; Feldmann R; Ullrich K
    Pediatrics; 2003 Dec; 112(6 Pt 2):1580-3. PubMed ID: 14654669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice.
    Mochizuki S; Mizukami H; Ogura T; Kure S; Ichinohe A; Kojima K; Matsubara Y; Kobayahi E; Okada T; Hoshika A; Ozawa K; Kume A
    Gene Ther; 2004 Jul; 11(13):1081-6. PubMed ID: 15057263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive profile of rats exposed to lactational hyperphenylalaninemia: correspondence with human mental retardation.
    Strupp BJ; Himmelstein S; Bunsey M; Levitsky DA; Kesler M
    Dev Psychobiol; 1990 Apr; 23(3):195-214. PubMed ID: 2379759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults.
    Moats RA; Moseley KD; Koch R; Nelson M
    Pediatrics; 2003 Dec; 112(6 Pt 2):1575-9. PubMed ID: 14654668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Brain sulfatides and cerebrosides in experimental hyperphenylalaninemia].
    Chaeva LS
    Vopr Med Khim; 1977; 23(5):646-9. PubMed ID: 563642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer.
    Ding Z; Georgiev P; Thöny B
    Gene Ther; 2006 Apr; 13(7):587-93. PubMed ID: 16319947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now?
    Sarkissian CN; Gámez A
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S22-6. PubMed ID: 16165390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral glycine content and phosphoserine phosphatase activity in hyperaminoacidemias.
    McChesney R; Isaacs CE; Greengard O
    Neurochem Res; 1987 Mar; 12(3):289-95. PubMed ID: 3035402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino acid depletion in the blood and brain tissue of hyperphenylalaninemic rats is abolished by the administration of additional lysine: a contribution to the understanding of the metabolic defects in phenylketonuria.
    Huether G; Kaus R; Neuhoff V
    Biochem Med; 1985 Jun; 33(3):334-41. PubMed ID: 3925942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired glutamatergic synaptic transmission in the PKU brain.
    Martynyuk AE; Glushakov AV; Sumners C; Laipis PJ; Dennis DM; Seubert CN
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S34-42. PubMed ID: 16153867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.